Back to Search
TIMOTHY STERLING, MD
MD
Infectious Disease Physician
NPI: 1801983929IndividualAccepts Medicare
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
MD37622(TN)
Education
COLUMBIA UNIVERSITY COLLEGE OF PHYSICIANS AND SURGEONS
Class of 1989
Research & Publications (20)
New approaches to the treatment of latent tuberculosis.
PMID 18810686·Semin Respir Crit Care Med·2008
6-review
Immune function in young children with previous pulmonary or miliary/meningeal tuberculosis and impact of BCG vaccination.
PMID 17908747·Pediatrics·2007
8-other
The scope and impact of treatment of latent tuberculosis infection in the United States and Canada.
PMID 16424442·Am J Respir Crit Care Med·2006
4-observational
Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors.
PMID 16704037·Int J Tuberc Lung Dis·2006
8-other
Transmission of Mycobacterium tuberculosis from health care workers.
PMID 16837674·N Engl J Med·2006
8-other
The WHO/IUATLD diagnostic algorithm for tuberculosis and empiric fluoroquinolone use: potential pitfalls.
PMID 15636484·Int J Tuberc Lung Dis·2004
6-review
Effect of early versus deferred antiretroviral therapy for HIV on survival.
PMID 19339714·N Engl J Med·2009
4-observational
Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care.
PMID 19220139·J Infect Dis·2009
8-other
Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiators.
PMID 19108987·J Clin Epidemiol·2009
8-other
Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapy.
PMID 19090776·J Infect Dis·2009
5-case
Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure.
PMID 19483111·Am J Respir Crit Care Med·2009
8-other
Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance.
PMID 19329799·J Antimicrob Chemother·2009
4-observational
Potentially preventable tuberculosis among HIV-infected persons in the era of highly active antiretroviral treatment.
PMID 19275796·Int J Tuberc Lung Dis·2009
8-other
Naso-temporal asymmetry for signals invisible to the retinotectal pathway.
PMID 18480367·J Neurophysiol·2008
8-other
A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax.
PMID 18077611·Clin Vaccine Immunol·2008
4-observational
Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors.
PMID 19110909·J Natl Med Assoc·2008
8-other
Normal chest radiography in pulmonary tuberculosis: implications for obtaining respiratory specimen cultures.
PMID 18371265·Int J Tuberc Lung Dis·2008
8-other
Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures.
PMID 18922071·Clin Infect Dis·2008
8-other
HIV in the workplace in Botswana: incidence, prevalence, and disease severity.
PMID 18160001·AIDS Res Hum Retroviruses·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 2220 Pierce Ave
Nashville, TN 37232 - Phone
- (615) 936-2000
Quick Facts
- NPI
- 1801983929
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile